Press Release 04.04.24
Gabriella Lombardi advises clients on multimillion- and billion-dollar securities matters, IPOs, mergers, acquisitions and other corporate finance transactions, representing in excess of $6 billion in value in the past two years.
Working with public and private companies in the technology, life sciences and other industries, Gabriella provides skilled counsel on complex public offerings, M&As, de-SPACs, private placements, divestitures and capital markets transactions. Gabriella also has extensive experience advising public companies on general corporate issues, ’33 and ’34 Act reporting and compliance, proxy matters, stock exchange compliance and initiatives, and Environmental, Social and Governance (ESG) and corporate governance issues. She also represents underwriters, placement agents, investment banks and initial purchasers in capital markets transactions.
Representative Experience
- Represented Invitae Corporation in its IPO, and subsequent equity and debt offerings and acquisitions, including its $1.15 billion 144A convertible note offering, $400 million ATM offering and $1.4 billion acquisition of ArcherDX.
- Represented Genomic Health, Inc. in its IPO and follow-on offerings and its acquisition by Exact Sciences Corporation for $2.8 billion.
- Represented Nikola Corporation in its $3.3 billion de-SPAC merger with VectoIQ Acquisition Corp., $525 million PIPE, and the listing of Nikola’s common stock on the Nasdaq Global Select market, as well as its aggregate $600 million equity lines of credit.
View More
- Represented Blockchain Coinvestors Acquisition Corp. in its acquisition of Qenta Inc.
- Representing eCombustible in its pending de-SPAC merger.
- Represented 8x8, Inc. in its $287.5 million 144A convertible note offering.
- Represented Vincerx Pharma, Inc. in its $280 million de-SPAC business combination with LifeSci Acquisition Corp. and the listing of Vincerx’s common stock on the Nasdaq Capital Market, as well as its recent $50.75 million PIPE.
- Represented BioLegend in its $5.25 billion acquisition by PerkinElmer, Inc.
- Advised Vital Therapies Inc. in its exchange agreement with Immunic AG.
- Represented Alliance Fiber Optic Products, Inc. in its acquisition by Corning Inc. after taking the company public nearly 16 years earlier.
- Represented Inphi Corp. in three 144A convertible note offerings.
- Represented Mission West Properties Inc. in the sale of its real estate assets valued at $1.3 billion.
- Represented Veracyte, Inc., in its IPO, PIPE, and follow-on offerings.
- Represented a medical device company in its IPO and subsequent registered direct and PIPE financings.
- Advised a semiconductor company in two 144A convertible senior note offerings.
- Represented a semiconductor company in its acquisition by TDK Corp.
- Advised a provider of broadband semiconductor and software products for the digital home in a follow-on offering.
- Represented a global provider of advanced flexible printed circuits and component assembly solutions in its IPO.
- Advised the underwriters in an IPO of a power semiconductor company.
- Advised the underwriters in a follow-on offering by a provider of semiconductor solutions for imaging, audio, video and embedded modem applications.
- Advised the underwriters in a registered direct offering by a semiconductor company.
- Advised the underwriters in the equity offering of a provider of fixed wireless voice and data products for the worldwide telecommunications market.
- Advised venture investors in a financing transaction for a provider of customer identity management software solutions.
- Represented a private financial services company in several financing transactions and in the acquisition of several complementary companies.
- Advised on a 144A convertible senior note offering by a provider of services in IT distribution, supply chain management and contract assembly.
- Represented the financial advisor in connection with the rendering of fairness opinions in numerous public merger transactions.
- Represented a consumer electronics company in the sale of three of its business lines under the supervision of the federal bankruptcy court.
- Advised the underwriters in connection with a follow-on offering for a manufacturer of reprogrammable memory products and analog and mixed-signal products.
- Advised a bank holding company in connection with its acquisition of several banks and bank holding companies.
- Represented two technology companies in separate delisting proceedings initiated by Nasdaq.
- Represented a provider of broadband semiconductor and software products for the digital home in a follow-on offering.
Professional Highlights
- Has spoken annually since 2009 at Liquidity Summits in San Francisco and Silicon Valley on IPOs.
- Section Editor, Venture Capital & Public Offering Negotiation, Third Edition, Part Three, Taking the Portfolio Company Public.
- “Best Laid Plans Gone Awry: Practices for Rule 10b5-1 Trading Plans,” Law360, May 14, 2013. Co-author.
View More
- Representative Speaking Engagements
- Winter Executive Liquidity Summit – IPO Nuts and Bolts, December 4, 2018.
- Annual Liquidity Summit – IPO Nuts and Bolts, March 2, 2018.
- Annual Liquidity Summit – IPO Markets and Considerations, with participants from JP Morgan, Hortonworks, Audentes and Connor Group, October 18, 2016.
- Austin Executive Summit – Nuts and Bolts – Raising Capital in Public and Private Markets, April 21, 2016.
- MedTech Women – IPOs, with participants from Ernst & Young, Intersect ENT, UBS and Veracyte, November 6, 2014.
- Annual Liquidity Summit – Jumping through a Window: How to fast-track your preparation for an IPO, with participants from Connor Group, Nimble Storage, Veracyte and Zendesk, July 14, 2014.
- Annual Liquidity Summit – Preparing to Launch: A plan of action and how to avoid bumps in the road on your path to an IPO or M&A, with participants from Deloitte & Touche, J.P. Morgan, Trulia and Woodruff-Sawyer, September 20, 2013.
- Annual Liquidity Summit – Preparing to Launch: A plan of action and how to avoid bumps in the road on your path to an IPO or M&A, with participants from Class V Group, Connor Group, Needham & Company, Tensilica, and Woodruff-Sawyer, March 21, 2013.
- Annual Liquidity Summit - Emergence of Secondary Markets and Potential New Funding Options for Private Issuers, with participants from Xpert Financial, Inc., Deloitte LLP, Woodruff-Sawyer & Co. and SecondMarket, Inc., March 13, 2012.
- Annual Liquidity Summit - IPO Nuts and Bolts, with participants from Connor Group, Krause Consulting, QuinStreet and Woodruff-Sawyer & Co., November 10, 2011.
- CFO Essentials Workshop: Updates and Practical Implications for CFOs, with participants from Baird and SingerLewak, December 2, 2010.
- Annual Liquidity Summit, with participants from August Capital, J.P. Morgan, Pagemill Partners and NASDAQ, November 3, 2010.
- Annual Liquidity Summit - Nuts and Bolts of Preparing an IPO: Requirements for going public, including filing requirements, management and board issues, due diligence, selecting advisors and choosing an exchange, including participants from Nasdaq, Needham & Company LLC and PricewaterhouseCoopers, December 10, 2009.
Education
-
J.D., University of San Francisco School of Law, 1988
B.A., University of San Francisco, 1985
cum laude
Admissions
-
California